Abstract | OBJECTIVES: To assess the therapeutic efficacy of chloroquine (CQ) treatment against uncomplicated Plasmodium falciparum infections in a tribal population of central India (Madhya Pradesh) and to investigate the prevalence of mutant P. falciparum chloroquine-resistant transporter (pfcrt) gene in the parasite population. METHODS: Clinical and parasitological response was determined by in-vivo testing. For molecular testing, the parasite DNA was extracted from blood samples and used to amplify and sequence parts of the pfcrt (44-177 codons), MSP1 (block 2) and MSP2 (central repeat region) genes. RESULTS: Of 463 patients presenting fever, 137 tested positive for P. falciparum. They were treated with CQ. Of these, 58% participated in the study. Overall, treatment failure occurred in 53% of participants. Children under 5 years of age showed significantly more CQ resistance than adults. Mutant genotype S(72)V(73)M(74)N(75)T(76) was prevalent among both CQ responders (61.29%) and non-responders (66.7%). Interestingly, several patients from the CQ non-responder group (33.3%, n = 39) were harbouring parasite with wild type C(72)V(73)M(74)N(75) K(76) genotype of the pfcrt gene. Microsatellite sequences downstream of exon 2 varied widely among both wild type and mutant pfcrt haplotypes. CONCLUSION: The high rate of treatment failure in the present study clearly indicates the need to reassess the use of CQ as first-line antimalarial therapy in central India. This is supported by the presence of mutant pfcrt genotype among majority of the parasite population of the CQ non-responder group of patients. However, the presence of wild type amino acid at codon 76 of the pfcrt gene among several patients with CQ non-responders requires further investigations.
|
Authors | Praveen Kumar Bharti, Mohammad Tauqeer Alam, Robert Boxer, Man Mohan Shukla, Sant P Gautam, Yagya D Sharma, Neeru Singh |
Journal | Tropical medicine & international health : TM & IH
(Trop Med Int Health)
Vol. 15
Issue 1
Pg. 33-40
(Jan 2010)
ISSN: 1365-3156 [Electronic] England |
PMID | 19912592
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Protozoan
- Antimalarials
- DNA, Protozoan
- Membrane Transport Proteins
- Merozoite Surface Protein 1
- PfCRT protein, Plasmodium falciparum
- Protozoan Proteins
- merozoite surface protein 2, Plasmodium
- Chloroquine
|
Topics |
- Adolescent
- Adult
- Age Factors
- Animals
- Antigens, Protozoan
(genetics)
- Antimalarials
(therapeutic use)
- Child
- Child, Preschool
- Chloroquine
(therapeutic use)
- DNA Mutational Analysis
(methods)
- DNA, Protozoan
(genetics)
- Drug Resistance
(genetics)
- Female
- Humans
- India
(epidemiology)
- Infant
- Malaria, Falciparum
(drug therapy, epidemiology, parasitology)
- Male
- Membrane Transport Proteins
(genetics)
- Merozoite Surface Protein 1
(genetics)
- Middle Aged
- Mutation
- Plasmodium falciparum
(genetics)
- Polymerase Chain Reaction
(methods)
- Protozoan Proteins
(genetics)
- Treatment Failure
- Young Adult
|